Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section
Public ClinicalTrials.gov record NCT03853694. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Active-Controlled Study to Evaluate the Efficacy and Safety of EXPAREL When Administered Via Infiltration Into the Transversus Abdominis Plane Versus Standard of Care in Subjects Undergoing Elective Cesarean Section (CHOICE)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare total opioid consumption by subjects in different treatment groups. Another purpose of this study is to assess how well EXPAREL works, collect any safety data and assess your satisfaction using EXPAREL.
Study identification
- NCT ID
- NCT03853694
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Interventions
- 50 mcg Duramorph+ EXPAREL + multi-modal pain regimen Drug
- 150 mcg Duramorph + multi-modal pain regimen Drug
- Exparel TAP + multi-modal pain regimen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 4, 2019 (Actual)
- Primary completion
- Jan 9, 2020 (Actual)
- Completion
- Jan 16, 2020 (Actual)
- Last update posted
- Jul 18, 2022
2019 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University School of Medicine | Stanford | California | 94305 | — |
| University of Florida- Gainesville | Gainesville | Florida | 32610 | — |
| University of Florida college of Medicine - Jacksonville | Jacksonville | Florida | 32209 | — |
| Clinical Research Prime | Idaho Falls | Idaho | 83404 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| St. Peter's University Medical Center | New Brunswick | New Jersey | 08901 | — |
| Columbia University Medical Center/NY Presbyterian Hospital | New York | New York | 10032 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Thomas Jefferson Medical Center | Philadelphia | Pennsylvania | 19107 | — |
| Magee-Women's Hospital of UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| The University of Texas Medical Branch | Galveston | Texas | 77555-0877 | — |
| Inova Health System | Falls Church | Virginia | 22042 | — |
| West Virginia University | Morgantown | West Virginia | 86506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03853694, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03853694 live on ClinicalTrials.gov.